top of page
H2C CLIENT TRANSACTIONS

H2C Leads Monetization Of 
19-Property Blood Plasma Collection 
Facility
 Portfolio 

July 2023

NEW YORK — H2C Securities Inc. (“H2C”), a healthcare-focused strategic advisory firm, served as the exclusive advisor to Collection Center Property Company, LLC (“CCPC”) on the monetization of a 19-property portfolio of blood plasma collection centers located across 13 states (“Portfolio”). 

In a transaction led by H2C Executive Director Matthew Tarpley and Vice President Michael Fioravanti, the Portfolio closed in five tranches over a 12-month period for a total of ±$136.7 million.   

The recently renovated Portfolio totaled 241,584 square feet and is leased to ImmunoTek, the leading independent blood plasma collection and development company in the U.S.  Each FDA-licensed facility features specialized improvements including medical-grade freezers, sterile processing areas, optimized donor floor layouts and loading docks, all ideal attributes for plasma collection operations.   

The highly competitive process attracted offers from a diverse group of investors including net-lease REITs, life science investors and institutional private equity groups. The transaction was structured to close in multiple tranches as facilities completed, which enabled CCPC to lock in pricing for the Portfolio in a rising-interest-rate environment.  

“We’re excited to close this transaction with H2C” said Joe Cridge, Director at Jadian Capital.  “Collection centers offer investors exposure to a mission-critical component of the plasma-derived therapeutics market which benefit from high rent coverage ratios and ‘sticky’ tenants relative to other healthcare real estate asset classes.”  

“H2C leveraged its track record of developing a deep expertise in “niche” healthcare assets to understand the components of the blood plasma industry in advance of the engagement, which allowed H2C to effectively deliver the inherent value these types of facilities hold as part of the larger life sciences and biopharma space. The CCPC team’s expertise in operating asset-intensive businesses was clear throughout the engagement, and we aligned quickly to do our part in delivering an optimal outcome as they enter the next phase of their business plan,” said Matthew Tarpley, Executive Director at H2C. Email Matthew. 

“This is a great outcome for CCPC, and we’re proud to have collaborated with CCPC in attaining optimal value for their investment,” Fioravanti said. Email Michael. 

The testimonial, statements and opinions presented are applicable to the client depicted.  The testimonials are voluntarily provided, unsolicited, and are non-representative of all clients. The testimonials are representative of the specific client’s experience, and the exact results and experience will be unique to each client. Unique experiences and past performance do not guarantee future results. 

About Collection Center Property Company, LLC & Jadian Capital, LP 
 

Collection Center Property Company is a Jadian Capital company and an affiliate of ImmunoTek Bio Centers (“ImmunoTek”), the leading independent plasma center developer and operator in the U.S. Together, ImmunoTek and CCPC provide comprehensive plasma supply, collection center fleet development and turn-key real estate solutions to the global pharmaceutical industry.  Currently scaled and capitalized to open up to 25 new plasma centers per year, CCPC and ImmunoTek are the preferred “one-stop-shop” partner for all plasma-related needs.    

  

Jadian Capital is an alternative investment firm operating at the intersection of real estate, private equity and structured solutions. Founded in 2017 and based in New York and Connecticut, Jadian invests throughout the capital structures of real estate, related assets and companies. 

About H2C Securities Inc. ("H2C")

H2C is a strategic advisory and investment banking firm committed to providing superior advice to healthcare organizations, higher education institutions, and related organizations throughout the United States. H2C’s professionals have a long track record of success in mergers and acquisitions, capital markets, and real estate transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value.

Securities and services offered through H2C Securities Inc., member FINRA/SIPC, a registered broker-dealer and an indirect subsidiary of Fifth Third Bank, National Association. All rights reserved. Securities and services offered through H2C Securities Inc.: Are Not FDIC Insured; Offer No Bank Guarantee; May Lose Value; Are Not Insured by any Federal Government Agency; Are Not a Deposit. 

For more information, visit h2c.com

bottom of page